These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

332 related items for PubMed ID: 32682086

  • 21. The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease.
    Fujii H, Kawada N, Japan Study Group Of Nafld Jsg-Nafld.
    Int J Mol Sci; 2020 May 29; 21(11):. PubMed ID: 32485838
    [Abstract] [Full Text] [Related]

  • 22. Serum homocysteine levels in patients with nonalcoholic fatty liver disease.
    Polyzos SA, Kountouras J, Patsiaoura K, Katsiki E, Zafeiriadou E, Deretzi G, Zavos C, Gavalas E, Katsinelos P, Mane V, Slavakis A.
    Ann Hepatol; 2012 May 29; 11(1):68-76. PubMed ID: 22166563
    [Abstract] [Full Text] [Related]

  • 23. The transcription factor c-Jun/AP-1 promotes liver fibrosis during non-alcoholic steatohepatitis by regulating Osteopontin expression.
    Schulien I, Hockenjos B, Schmitt-Graeff A, Perdekamp MG, Follo M, Thimme R, Hasselblatt P.
    Cell Death Differ; 2019 Sep 29; 26(9):1688-1699. PubMed ID: 30778201
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management.
    McPherson S, Hardy T, Henderson E, Burt AD, Day CP, Anstee QM.
    J Hepatol; 2015 May 29; 62(5):1148-55. PubMed ID: 25477264
    [Abstract] [Full Text] [Related]

  • 26. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
    Kabbany MN, Conjeevaram Selvakumar PK, Watt K, Lopez R, Akras Z, Zein N, Carey W, Alkhouri N.
    Am J Gastroenterol; 2017 Apr 29; 112(4):581-587. PubMed ID: 28195177
    [Abstract] [Full Text] [Related]

  • 27. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes.
    Bayliss J, Ooi GJ, De Nardo W, Shah YJH, Montgomery MK, McLean C, Kemp W, Roberts SK, Brown WA, Burton PR, Watt MJ.
    Front Endocrinol (Lausanne); 2021 Apr 29; 12():642432. PubMed ID: 33746906
    [Abstract] [Full Text] [Related]

  • 28. Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease.
    Rosso C, Kazankov K, Younes R, Esmaili S, Marietti M, Sacco M, Carli F, Gaggini M, Salomone F, Møller HJ, Abate ML, Vilstrup H, Gastaldelli A, George J, Grønbæk H, Bugianesi E.
    J Hepatol; 2019 Nov 29; 71(5):1012-1021. PubMed ID: 31301321
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Metabolic drivers of non-alcoholic fatty liver disease.
    Bence KK, Birnbaum MJ.
    Mol Metab; 2021 Aug 29; 50():101143. PubMed ID: 33346069
    [Abstract] [Full Text] [Related]

  • 31. Plasma Fibroblast Growth Factor 21 Is Associated With Severity of Nonalcoholic Steatohepatitis in Patients With Obesity and Type 2 Diabetes.
    Barb D, Bril F, Kalavalapalli S, Cusi K.
    J Clin Endocrinol Metab; 2019 Aug 01; 104(8):3327-3336. PubMed ID: 30848827
    [Abstract] [Full Text] [Related]

  • 32. Genetic Variants Associated With Obesity and Insulin Resistance in Hispanic Boys With Nonalcoholic Fatty Liver Disease.
    Rausch JC, Lavine JE, Chalasani N, Guo X, Kwon S, Schwimmer JB, Molleston JP, Loomba R, Brunt EM, Chen YI, Goodarzi MO, Taylor KD, Yates KP, Rotter JI, NASH Clinical Research Network.
    J Pediatr Gastroenterol Nutr; 2018 May 01; 66(5):789-796. PubMed ID: 29470286
    [Abstract] [Full Text] [Related]

  • 33. Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity.
    Di Mauro S, Scamporrino A, Petta S, Urbano F, Filippello A, Ragusa M, Di Martino MT, Scionti F, Grimaudo S, Pipitone RM, Privitera G, Di Pino A, Scicali R, Valenti L, Dongiovanni P, Fracanzani A, Rabuazzo AM, Craxì A, Purrello M, Purrello F, Piro S.
    Liver Int; 2019 Sep 01; 39(9):1742-1754. PubMed ID: 31169972
    [Abstract] [Full Text] [Related]

  • 34. Pathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis.
    Park BH, Yoon JM, Kim JH, Moon JH, Lee YH, Jang SM, Kim YJ.
    Yonsei Med J; 2017 Jul 01; 58(4):756-762. PubMed ID: 28540988
    [Abstract] [Full Text] [Related]

  • 35. FICK-3 Score Combining Fibrosis-4, Insulin Resistance and Cytokeratin-18 in Predicting Non-alcoholic Steatohepatitis in NAFLD Egyptian Patients.
    Mohammed MA, Omar NM, Mohammed SA, Amin AM, Gad DF.
    Pak J Biol Sci; 2019 Jan 01; 22(10):457-466. PubMed ID: 31930835
    [Abstract] [Full Text] [Related]

  • 36. Glycemic Control Predicts Severity of Hepatocyte Ballooning and Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease.
    Alexopoulos AS, Crowley MJ, Wang Y, Moylan CA, Guy CD, Henao R, Piercy DL, Seymour KA, Sudan R, Portenier DD, Diehl AM, Coviello AD, Abdelmalek MF.
    Hepatology; 2021 Sep 01; 74(3):1220-1233. PubMed ID: 33724511
    [Abstract] [Full Text] [Related]

  • 37. Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease.
    Luukkonen PK, Zhou Y, Sädevirta S, Leivonen M, Arola J, Orešič M, Hyötyläinen T, Yki-Järvinen H.
    J Hepatol; 2016 May 01; 64(5):1167-1175. PubMed ID: 26780287
    [Abstract] [Full Text] [Related]

  • 38. FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis.
    Coilly A, Desterke C, Guettier C, Samuel D, Chiappini F.
    Sci Rep; 2019 Dec 24; 9(1):19785. PubMed ID: 31874999
    [Abstract] [Full Text] [Related]

  • 39. Lipid zonation and phospholipid remodeling in nonalcoholic fatty liver disease.
    Hall Z, Bond NJ, Ashmore T, Sanders F, Ament Z, Wang X, Murray AJ, Bellafante E, Virtue S, Vidal-Puig A, Allison M, Davies SE, Koulman A, Vacca M, Griffin JL.
    Hepatology; 2017 Apr 24; 65(4):1165-1180. PubMed ID: 27863448
    [Abstract] [Full Text] [Related]

  • 40. Adipose Tissue Insulin Resistance Predicts the Severity of Liver Fibrosis in Patients With Type 2 Diabetes and NAFLD.
    Kalavalapalli S, Leiva EG, Lomonaco R, Chi X, Shrestha S, Dillard R, Budd J, Romero JP, Li C, Bril F, Samraj G, Pennington J, Townsend P, Orlando F, Shetty S, Mansour L, Silva-Sombra LR, Bedossa P, Malaty J, Barb D, Gurka MJ, Cusi K.
    J Clin Endocrinol Metab; 2023 Apr 13; 108(5):1192-1201. PubMed ID: 36378995
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.